1.1 About the Commercialization Priming Program

See above

1.2 Key Dates

Applications are accepted at any time and are reviewed at quarterly meetings, according to the following general schedule.

• August 15
• November 15
• February 15
• May 15

Applications received by these dates will be reviewed within two months.

1.3 Applicant Eligibility and Limitation

Principal Investigator (PI) Eligibility

• 不良研究所 faculty members who hold the role of Assistant Professor, Associate Professor, or Full Professor.
• Eligible to hold Tri-Agency research funding.

Co-Investigator (Co-I) Eligibility

• 不良研究所 faculty members who hold the role of Assistant Professor, Associate Professor, or Full Professor.
• Researchers from D2R鈥檚 partner institutions (McMaster University, University of British Columbia, University of Ottawa, and Universit茅 de Sherbrooke). These researchers must be on the approved list of researchers that was provided by the partners. Contact d2r.funding [at] mcgill.ca for list of eligible faculty members from our partner institutions.
• Eligible to hold Tri-Agency research funding.

Collaborators

• Individuals from 不良研究所, other academic institutions, industry, government, or community organizations, who play an active role in the research and research-related activities of the project. Collaborators are not eligible to receive funding from D2R.

Partner Organizations

• Organizations are government, industry, associations, non-profit organizations or other institutions that have contributed or committed cash or in-kind contributions to support the proposed research.

1.4 Application Limits

• There is no limit to the number of applications a Principal Investigator or Co-Investigator can submit to this D2R program.
• There are no restrictions on holding multiple awards or roles concurrently under this program.

1.5 Award Value per Project and Duration

The amount per award is between $50,000 and $100,000 for up to 12 months (non-renewable).

1.6 Eligible Expenses

Eligible expenses include salaries and benefits, stipends, materials and supplies, travel, and service contracts. For additional information, refer to the

Application consists of an with documents to upload, detailed below.

In addition, the PI must complete the before submitting an application to this program. Only one Self-Identification Survey is needed per PI; if one has already been completed as part of applying to another D2R program, this survey does not have to be repeated.

Once the online application form and Equity Self-Identification Survey has been completed, the PI must email D2R.funding [at] mcgill.ca (subject: Commercialization%20Priming%20program%20application) to inform the office that you have submitted your application online.

2.1 Document Requirements

Use the template for each document:

• Project Description (2.2) (Template)
• Biosketches (2.3) (Template)
• Budget & Justification (2.4) (Template)
• Reviewer Suggestions (2.5) (Template)
• Letter of Support (if applicable) (2.6)

2.2 Project Description

Use the template provided. Adhere to the following page limits for the Project Description section.

• Applications written in English: 7 pages, inclusive of references.
• Applications written in French: 8 pages, inclusive of references.

Figures and images may be used but must fit within the stated page limit. Appendices are not permitted.

Submissions that exceed the maximum page limit will have the extra pages removed prior to review.

Project Description Instructions

A. Summary (Suggested Length: 0.5 Page in either English or French)

• Provide an overview of the project's objectives, methods, anticipated outcomes, and potential commercial benefits. Highlight how the project could attract further partnerships and funding.

B. Introduction, Background, and D2R Alignment (Suggested Length: 1 Page in either English or French)

• Offer background information and context, including prior work related to the discovery, technology, concept, or invention by the Principal Investigator or others.
• Detail the project's alignment with D2R鈥檚 Foundational Axes and strategic priorities, and how the innovation will contribute to D2R's mission.

C. Research Plan (Suggested Length: 3 Pages in English, 4 Pages in French)

• Outline the primary objective and specific aims, focusing on innovation and potential commercialization. Describe methods, highlighting approaches and expected deliverables. Discuss potential contributions, unique aspects for marketability, and the experimental plan.
• Explain how Equity, Diversity and Inclusion (EDI) factors have been integrated into the research design and the intersections of factors (including but not limited to sex, gender, physical ability, Indigeneity, race, and age). If EDI considerations are not applicable, provide an evidence-based rationale. Note: To learn more about integrating EDI into research design refer to resources from , , and .

D. Research Team (Suggested Length: 0.5 Page in either English or French)

• Describe the research team, individual expertise, contributions, and current partners.

E. Commercialization Strategy (Suggested Length: 1 Page in either English or French)

• Describe the current stage of the technology's development (from conceptualization, proof of concept established, prototype, to invention).
• Indicate if the technology has been published in any form, and how this affects its commercialization potential.
• Outline what key objectives need to be completed for the technology to be ready for commercialization, including the required timeline.
• Explain how the proposed activities will advance the technology to a go/no-go scenario for commercial development.
• Identify the market your technology aims to address.
• Describe any commercially available products that solve a similar or identical problem.
• Detail the potential for future funding and partnerships.

F. Budget (Suggested Length: 0.5 Page in either English or French)

• Justify the need for D2R funding and provide a narrative summary of the budget with justifications for key items.

G. References (Suggested Length: 0.5 Page in either English or French)

• List works cited, including DOIs where available.

2.3 Biosketch

• Use the template provided.
• A biosketch is required for the Principal Investigator, each Co-Investigator, and any Postdoctoral Fellow(s). Biosketches for Collaborators are not required.
• Compile all biosketches into one PDF file before uploading.

2.4 Budget and Justification

• Use the Excel template provided.

2.5 Reviewer Suggestions

• Suggestions of external reviewers. Use the Excel template provided.

2.6 Letters of Support (if applicable)

If Applicable. Upload a letter of support from each partnering organization. If there are multiple partners and letters of support, they should be compiled into a single PDF.

2.7 Application submission

Once the online application form and Equity Self-Identification Survey have been completed, the PI must email D2R.funding [at] mcgill.ca (subject: Commercialization%20Priming%20program%20application) to inform the office that you have submitted your application online.

Following the administrative review of the Principal Investigator and Co-Investigator(s)' eligibility, budget appropriateness, and completeness of the application, all applications will be reviewed by a committee of experts in the field (scientific and business) for the following:

Alignment with D2R鈥檚 Mission

• Alignment with D2R鈥檚 mandate, axes, and priorities
• Alignment with the mandate of the Commercialization Priming funding program

Merit Review

• Originality and innovation
• Capacity of the research plan to carry out the innovation or develop the technology
• Feasibility of completing the project and specific aims within the timeframe of the proposal
• Quality and contributions of the researchers to the research
• Commercial potential

EDI in the research design will be assessed as satisfactory, insufficient, or inadequate. For projects deemed fundable, Principal Investigators will be notified of any issues with EDI in the research design. Applicants will have the opportunity to revise this section, which must be satisfactorily updated and approved before the release of funds.

4.1 Funding Decision

The D2R Research Steering Committee (RSC) will review the evaluation committee鈥檚 report, and will consider the project's relevance to D2R's strategic goals and the program budget in its funding decisions.

4.2 G茅nome Qu茅bec Co-Funding

Applications that align with G茅nome Qu茅bec鈥檚 mission of genomics research may be selected for co-funding by G茅nome Qu茅bec.听听

As per G茅nome Qu茅bec policy, one sixth (1/6) of the Net Revenues resulting from the commercialization of any funded project鈥檚 Intellectual Property will be remitted to G茅nome Qu茅bec, for the purpose of promoting and funding genomics research activities in Quebec.听

4.3 Announcement of Results

In general, Principal Investigators will be informed of the results by email within two months of the application deadline.

4.4 Notice of Award

Successful applicants will receive a Notice of Award (NoA), which details the terms, conditions, and reporting obligations.

Successful applicants must complete the D2R Award Acceptance Form and 不良研究所鈥檚 Office of Sponsored Research (OSR) Checklist within two weeks of receiving the NoA. In addition, awardees must obtain all necessary documentation related to ethics, biohazards, and animal care approvals before funds are disbursed.

Email: D2R.Funding [at] mcgill.ca (subject: Commercialization%20Priming%20application)